April 3, 2026 Posted by: Categories: No Comments The European Medicines Agency (EMA) published updated information on several medicines: Wegovy | European Medicines Agency (EMA) Tecentriq | European Medicines Agency (EMA) Finlee | European Medicines Agency (EMA) Hepcludex | European Medicines Agency (EMA) Alecensa | European Medicines Agency (EMA) Erleada | European Medicines Agency (EMA) Brilique | European Medicines Agency (EMA) Topotecan Hospira | European Medicines Agency (EMA) RoActemra | European Medicines Agency (EMA) Winrevair | European Medicines Agency (EMA) Beyfortus | European Medicines Agency (EMA)
